{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T14:37:55Z","timestamp":1778855875635,"version":"3.51.4"},"reference-count":116,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T00:00:00Z","timestamp":1697068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T00:00:00Z","timestamp":1697068800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002839","name":"Charit\u00e9 - Universit\u00e4tsmedizin Berlin","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002839","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Parasit."],"published-print":{"date-parts":[[2023,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Malaria is one of the most dangerous infectious diseases in the world. It occurs in tropical and subtropical regions and affects about 40% of the world\u00b4s population. In endemic regions, an estimated 200 million people contract malaria each year. Three-quarters of all global deaths (about 600 per year) are children under 5 years of age. Thus, malaria is one of the most relevant tropical and also childhood diseases in the world. Thanks to various public health measures such as vector control through mosquito nets or the targeted use of insecticides as well as the use of antimalarial prophylaxis drugs, the incidence has already been successfully reduced in recent years. However, to reduce the risk of malaria and to protect children effectively, further measures are necessary. An important part of these measures is an effective vaccination against malaria. However, the history of research shows that the development of an effective malaria vaccine is not an easy undertaking and is associated with some complications. Research into possible vaccines began as early as the 1960s. However, the results achieved were rather sobering and the various vaccines fell short of their expectations. It was not until 2015 that the vaccine RTS,S\/AS01 received a positive evaluation from the European Medicines Agency. Since then, the vaccine has been tested in Africa. However, with the COVID-19 pandemic, there are new developments in vaccine research that could also benefit malaria research. These include, among others, the so-called mRNA vaccines. Already in the early 1990s, an immune response triggered by an mRNA vaccine was described for the first time. Since then, mRNA vaccines have been researched and discussed for possible prophylaxis. However, it was not until the COVID-19 pandemic that these vaccines experienced a veritable progress. mRNA vaccines against SARS-CoV-2 were rapidly developed and achieved high efficacy in studies. Based on this success, it is not surprising that companies are also focusing on other diseases and pathogens. Besides viral diseases, such as influenza or AIDS, malaria is high on this list. Many pharmaceutical companies (including the German companies BioNTech and CureVac) have already confirmed that they are researching mRNA vaccines against malaria. However, this is not an easy task. The aim of this article is to describe and discuss possible antigens that could be considered for mRNA vaccination. However, this topic is currently still very speculative.<\/jats:p>","DOI":"10.1007\/s11686-023-00712-y","type":"journal-article","created":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T16:02:45Z","timestamp":1697126565000},"page":"916-928","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Malaria &amp; mRNA Vaccines: A Possible Salvation from One of the Most Relevant Infectious Diseases of the Global South"],"prefix":"10.1007","volume":"68","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9368-6985","authenticated-orcid":false,"given":"Yannick","family":"Borkens","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,10,12]]},"reference":[{"issue":"6","key":"712_CR1","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1109\/MPUL.2016.2607138","volume":"7","author":"J Banks","year":"2016","unstructured":"Banks J (2016) Target malaria has a killer in its sights: eliminating the world?s deadliest disease has been a priority for decades, and thanks to innovative gene-drive technology, target malaria is getting closer to achieving that goal. IEEE Pulse 7(6):30\u201333. https:\/\/doi.org\/10.1109\/MPUL.2016.2607138","journal-title":"IEEE Pulse"},{"key":"712_CR2","unstructured":"RKI (2015) Malaria: RKI-Ratgeber. Robert Koch-Institut. https:\/\/www.rki.de\/DE\/Content\/Infekt\/EpidBull\/Merkblaetter\/Ratgeber_Malaria.html. Accessed 16 Feb 2022"},{"issue":"2","key":"712_CR3","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1007\/s00292-014-1940-0","volume":"36","author":"K Hussein","year":"2015","unstructured":"Hussein K, Brix A, Matin E, Jonigk D (2015) Tutanchamun: Evidenzbasierte Paleopathologie vs. \u201eFluch des Pharao\u201c. Pathologe 36(2):186\u2013192. https:\/\/doi.org\/10.1007\/s00292-014-1940-0","journal-title":"Pathologe"},{"issue":"4","key":"712_CR4","first-page":"428","volume":"42","author":"R Korte","year":"1991","unstructured":"Korte R, Rehle T, Merkle A (1991) Strategies to maintain health in the Third World. Trop Med Parasitol 42(4):428\u2013432","journal-title":"Trop Med Parasitol"},{"issue":"3","key":"712_CR5","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1111\/dewb.12182","volume":"18","author":"MJ Tosam","year":"2018","unstructured":"Tosam MJ, Chi PC, Munung NS, Oukem-Boyer OOM, Tangwa GB (2018) Global health inequalities and the need for solidarity: a view from the Global South. Dev World Bioeth 18(3):241\u2013249. https:\/\/doi.org\/10.1111\/dewb.12182","journal-title":"Dev World Bioeth"},{"issue":"5","key":"712_CR6","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1645\/19-198","volume":"107","author":"AH Beavogui","year":"2021","unstructured":"Beavogui AH, Cherif MS, Camara BS, Delamou A, Kolie D, Ciss\u00e9 A, Camara D, Sow A, Camara G, Yattara M, Goumou N, Doumbouya A, Kourouma K, Diarra B, Dijmde A (2021) Prevalence of parasitic infections in children of Boke. Guinea J Parasitol 107(5):783\u2013789. https:\/\/doi.org\/10.1645\/19-198","journal-title":"Guinea J Parasitol"},{"issue":"12","key":"712_CR7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0030473","volume":"3","author":"S Hay","year":"2006","unstructured":"Hay S, Snow PW (2006) The malaria atlas project: developing global maps of malaria risk. PLoS Med 3(12):e473. https:\/\/doi.org\/10.1371\/journal.pmed.0030473","journal-title":"PLoS Med"},{"issue":"6","key":"712_CR8","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.pt.2011.01.003","volume":"27","author":"AP Patil","year":"2011","unstructured":"Patil AP, Gething PW, Piel FB, Hay SI (2011) Bayesian geostatistics in health cartography: the perspective of malaria. Trends Parasitol 27(6):246\u2013253. https:\/\/doi.org\/10.1016\/j.pt.2011.01.003","journal-title":"Trends Parasitol"},{"key":"712_CR9","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s12936-015-0574-x","volume":"14","author":"DJ Weiss","year":"2015","unstructured":"Weiss DJ, Mappin B, Dalrymple U, Bhatt S, Cameron E, Hay SI, Gething PW (2015) Re-examining environmental correlates of Plasmodium falciparum malaria endemicity: a data-intensive variable selection approach. Malar J 14:68. https:\/\/doi.org\/10.1186\/s12936-015-0574-x","journal-title":"Malar J"},{"issue":"2","key":"712_CR10","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1093\/oxfordjournals.bmb.a071746","volume":"38","author":"RS Bray","year":"1982","unstructured":"Bray RS, Garnham PC (1982) The life-cycle of primate malaria parasites. Br Med Bull 38(2):117\u2013122. https:\/\/doi.org\/10.1093\/oxfordjournals.bmb.a071746","journal-title":"Br Med Bull"},{"issue":"5","key":"712_CR11","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1645\/19-199","volume":"107","author":"AH Beavogui","year":"2021","unstructured":"Beavogui AH, Diawara EY, Cherif MS, Delamou A, Diallo N, Traore A, Millimouno P, Camara D, Sylla MM, Toure AA, Diallo MS, Toure S, Togo A, Camara G, Kourouma K, Sagara I, Dicko A, Dijmde A (2021) Selection of PFCRT 76T and PFMDR1 86Y mutant Plasmodium falciparum after treatment of uncomplicated malaria with artesunate-amodiaquine in Republic of Guinea. J Parasitol 107(5):778\u2013782. https:\/\/doi.org\/10.1645\/19-199","journal-title":"J Parasitol"},{"key":"712_CR12","unstructured":"Min\u00e1\u0159 J (1974) Results of the Czechoslovak-Iranian entomological expedition to Iran 1970. No 6: Diptera: Culicidae. Acta Ent Musei Nat Pragae (suppl6):87\u201389"},{"issue":"2","key":"712_CR13","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.actatropica.2008.09.017","volume":"109","author":"TK Barik","year":"2009","unstructured":"Barik TK, SahuSwain BBV (2009) A review on Anopheles culicifacies: from bionomics to control with special reference to Indian subcontinent. Acta Trop 109(2):87\u201397. https:\/\/doi.org\/10.1016\/j.actatropica.2008.09.017","journal-title":"Acta Trop"},{"issue":"7","key":"712_CR14","doi-asserted-by":"publisher","first-page":"2671","DOI":"10.1007\/s00436-016-5014-5","volume":"115","author":"N Becker","year":"2016","unstructured":"Becker N, Pfitzner WP, Czajka C, Kaiser A, Weitzel T (2016) Anopheles (Anopheles) petragnani Del Vecchio 1939\u2014a new mosquito species for Germany. Parasitol Res 115(7):2671\u20132677. https:\/\/doi.org\/10.1007\/s00436-016-5014-5","journal-title":"Parasitol Res"},{"issue":"2","key":"712_CR15","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1111\/mve.12431","volume":"34","author":"CL Culverwell","year":"2020","unstructured":"Culverwell CL, Vapalahti OP, Harbach RE (2020) Anopheles daciae, a new country record for Finland. Med Vet Entomol 34(2):145\u2013150. https:\/\/doi.org\/10.1111\/mve.12431","journal-title":"Med Vet Entomol"},{"issue":"4","key":"712_CR16","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1007\/s00436-010-2232-0","volume":"108","author":"K Raghavendra","year":"2011","unstructured":"Raghavendra K, Barik TK, Reddy BPN, Sharma P, Dash AP (2011) Malaria vector control: from past to future. Parasitol Res 108(4):757\u2013779. https:\/\/doi.org\/10.1007\/s00436-010-2232-0","journal-title":"Parasitol Res"},{"issue":"5","key":"712_CR17","doi-asserted-by":"publisher","first-page":"459","DOI":"10.16250\/j.32.1374.2020174","volume":"32","author":"JL Li","year":"2020","unstructured":"Li JL, Zhou HY, Tang JX, Zhu GD, Cao J (2020) Strategies and studies in malaria vector control in Jiangsu Province. Chin J Schisto Control 32(5):459\u2013463. https:\/\/doi.org\/10.16250\/j.32.1374.2020174","journal-title":"Chin J Schisto Control"},{"issue":"8767","key":"712_CR18","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/0140-6736(91)90657-b","volume":"338","author":"JP Velema","year":"1991","unstructured":"Velema JP (1991) Malaria, bednets, and mortality. Lancet 338(8767):642. https:\/\/doi.org\/10.1016\/0140-6736(91)90657-b","journal-title":"Lancet"},{"key":"712_CR19","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000363","author":"C Lengeler","year":"2000","unstructured":"Lengeler C (2000) Insecticide-treated bednets and curtains for preventing malaria. Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD000363","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"712_CR20","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/s41564-019-0607-2","volume":"5","author":"GPD Murray","year":"2020","unstructured":"Murray GPD, Lissenden N, Jones J, Voloshin V, To\u00e9 KH, Sherrard-Smith E, Foster GM, Churcher TS, Parker JEA, Towers CE, N\u2019Fal\u00e9 S, Guelbeogo WM, Ranson H, Towers D, McCall PJ (2020) Barrier bednets target malaria vectors and expand the range of usable insecticides. Nat Microbiol 5(1):40\u201347. https:\/\/doi.org\/10.1038\/s41564-019-0607-2","journal-title":"Nat Microbiol"},{"issue":"2","key":"712_CR21","first-page":"174","volume":"94","author":"JF Trape","year":"2001","unstructured":"Trape JF (2001) Contre\u202f: Les limited des moustiquaires impr\u00e9gn\u00e9es dans la lutte contre le paludisme en Afrique tropicale. Bull Soc Pathol Exot 94(2):174\u2013179","journal-title":"Bull Soc Pathol Exot"},{"issue":"1","key":"712_CR22","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1186\/s12936-020-03298-2","volume":"19","author":"R Kumar","year":"2020","unstructured":"Kumar R, Farzeen M, Hafeez A, Achakzai BK, Vankwani M, Lal M, Iqbal R, Somrongthong R (2020) Effectiveness of a health education intervention on the use of long-lasting insecticidal nets for the prevention of malaria in pregnant women of Pakistan: a quasi-experimental study. Malar J 19(1):232. https:\/\/doi.org\/10.1186\/s12936-020-03298-2","journal-title":"Malar J"},{"issue":"1","key":"712_CR23","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1128\/CMR.5.1.26","volume":"5","author":"FB Cogswell","year":"1992","unstructured":"Cogswell FB (1992) The hypnozoite and relapse in primate malaria. Clin Microbiol Rev 5(1):26\u201335. https:\/\/doi.org\/10.1128\/CMR.5.1.26","journal-title":"Clin Microbiol Rev"},{"key":"712_CR24","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1146\/annurev.ento.43.1.519","volume":"43","author":"JC Beier","year":"1998","unstructured":"Beier JC (1998) Malaria parasite development in mosquitoes. Annu Rev Entomol 43:519\u2013543. https:\/\/doi.org\/10.1146\/annurev.ento.43.1.519","journal-title":"Annu Rev Entomol"},{"issue":"10","key":"712_CR25","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1111\/j.1462-5822.2006.00778.x","volume":"8","author":"K Matuschewski","year":"2006","unstructured":"Matuschewski K (2006) Getting infectious: formation and maturation of Plasmodium sporozoites in the Anopheles vector. Cell Microbiol 8(10):1547\u20131556. https:\/\/doi.org\/10.1111\/j.1462-5822.2006.00778.x","journal-title":"Cell Microbiol"},{"key":"712_CR26","unstructured":"Spectrum News Staff (2021) BioNTech says it will create an mRNA-based vaccine to prevent malaria. Spectrum News 1. https:\/\/spectrumnews1.com\/ky\/lexington\/news\/2021\/07\/26\/biontech-malaria-vaccine-mrna-covid. Accessed 10 Nov 2021"},{"key":"712_CR27","unstructured":"CureVac, Sch\u00fcller T (2018) CureVac entwickelt innovative mRNA-Impfstoffe gegen Influenza und Malaria. CureVac. https:\/\/www.curevac.com\/2018\/02\/18\/curevac-entwickelt-innovative-mrna-impfstoffe-gegen-influenza-und-malaria\/. Accessed 10 Nov 2021"},{"key":"712_CR28","unstructured":"BMZ (2021) Neue Partnerschaft f\u00fcr Entwicklung, Frieden und Zukunft: Ein Marshallplan mit Afrika. Bundesministerium f\u00fcr wirtschaftliche Zusammenarbeit und Entwicklung. https:\/\/www.bmz.de\/de\/laender\/marshallplan-mit-afrika. Accessed 28 Nov 2021"},{"key":"712_CR29","unstructured":"Majambere S (no date) Ending malaria in Africa needs to focus on poverty: quick fixes won\u00b4t cut it. The Conversation. https:\/\/theconversation.com\/ending-malaria-in-africa-needs-to-focus-on-poverty-quick-fixes-wont-cut-it-169205. Accessed 28 Nov 2021"},{"issue":"4776","key":"712_CR30","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/190576a0","volume":"190","author":"S Brenner","year":"1961","unstructured":"Brenner S, Jacob F, Meselson M (1961) An unstable intermediate carrying information from genes to ribosomes for protein synthesis. Nature 190(4776):576\u2013581. https:\/\/doi.org\/10.1038\/190576a0","journal-title":"Nature"},{"issue":"1","key":"712_CR31","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1716153","volume":"379","author":"D Adams","year":"2018","unstructured":"Adams D, Gonzales-Duarte A, O\u2019Riordan W, Yang CC, Ueda M, Kristen AV, Tournev I, Schmidt HH, Coelho T, Berk JL, Lin KP, Vita G, Attarian S, Plent\u00e9-Bordeneuve V, Mezei MM, Campistol JM, Buades J, Brannagan TH 3rd, Kim BJ, Oh J, Parman Y, Sekijma Y, Hawkins PN, Solomon SD, Polydefkis M, Dyck PJ, Gandhi PJ, Goyal S, Chen J, Strahs AL, Nochur SV, Sweetser MT, Garg PP, Vaishnaw AK, Gollob JA, Suhr OB (2018) Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis. N Engl J Med 379(1):11\u201321. https:\/\/doi.org\/10.1056\/NEJMoa1716153","journal-title":"N Engl J Med"},{"issue":"9","key":"712_CR32","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1038\/nbt0918-777","volume":"36","author":"K Garber","year":"2018","unstructured":"Garber K (2018) Alnylam launches era of RNAi drugs. Nat Biotechnol 36(9):777\u2013778. https:\/\/doi.org\/10.1038\/nbt0918-777","journal-title":"Nat Biotechnol"},{"issue":"1","key":"712_CR33","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/0022-2836(71)90207-5","volume":"61","author":"CD Lane","year":"1971","unstructured":"Lane CD, Marbaix G, Gurdon JB (1971) Rabbit haemoglobin synthesis in frog cells: the translation of reticulocyte 9 s RNA in frog oocytes. J Mol Biol 61(1):73\u201391. https:\/\/doi.org\/10.1016\/0022-2836(71)90207-5","journal-title":"J Mol Biol"},{"issue":"5674","key":"712_CR34","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1038\/274921a0","volume":"274","author":"MJ Ostro","year":"1978","unstructured":"Ostro MJ, Giacomoni D, Lavelle D, Paxton W, Dray S (1978) Evidence for translation of rabbit globin mRNA after liposome-mediated insertion into a human cell line. Nature 274(5674):921\u2013923. https:\/\/doi.org\/10.1038\/274921a0","journal-title":"Nature"},{"issue":"5674","key":"712_CR35","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1038\/274923a0","volume":"274","author":"GJ Dimitriadis","year":"1978","unstructured":"Dimitriadis GJ (1978) Translation of rabbit globin mRNA introduced by liposomes into mouse lymphocytes. Nature 274(5674):923\u2013924. https:\/\/doi.org\/10.1038\/274923a0","journal-title":"Nature"},{"issue":"16","key":"712_CR36","doi-asserted-by":"publisher","first-page":"6077","DOI":"10.1073\/pnas.86.16.6077","volume":"86","author":"RW Malone","year":"1989","unstructured":"Malone RW, Felgner PL, Verma IM (1989) Cationic liposome-mediated RNA transfection. Proc Natl Acad Sci U S A 86(16):6077\u20136081. https:\/\/doi.org\/10.1073\/pnas.86.16.6077","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4949 Pt 1","key":"712_CR37","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1126\/science.1690918","volume":"247","author":"JA Wolff","year":"1990","unstructured":"Wolff JA, Malone RW, Williams P, Chong W, Acsadi G, Jani A, Felgner PL (1990) Direct gene transfer into mouse muscle in vivo. Science 247(4949 Pt 1):1465\u20131468. https:\/\/doi.org\/10.1126\/science.1690918","journal-title":"Science"},{"issue":"16","key":"712_CR38","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1016\/0264-410x(94)90074-4","volume":"12","author":"X Zhou","year":"1994","unstructured":"Zhou X, Berglund P, Rhodes G, Parker SE, Jondal M, Liljestr\u00f6m P (1994) Self-replicating Semliki Forest virus RNA as recombinant vaccine. Vaccine 12(16):1510\u20131514. https:\/\/doi.org\/10.1016\/0264-410x(94)90074-4","journal-title":"Vaccine"},{"key":"712_CR39","doi-asserted-by":"publisher","first-page":"100766","DOI":"10.1016\/j.nantod.2019.100766","volume":"28","author":"R Verbeke","year":"2019","unstructured":"Verbeke R, Lentacker I, De Smedt SC, Dewitte H (2019) Three decades of messenger RNA vaccine development. Nano Today 28:100766. https:\/\/doi.org\/10.1016\/j.nantod.2019.100766","journal-title":"Nano Today"},{"issue":"7","key":"712_CR40","first-page":"1397","volume":"55","author":"RM Conry","year":"1995","unstructured":"Conry RM, LoBuglio AF, Wright M, Sumerel L, Pike MJ, Johanning F, Benjamin R, Lu D, Curiel DT (1995) Characterization of a messenger RNA polynucleotide vaccine vector. Cancer Res 55(7):1397\u20131400","journal-title":"Cancer Res"},{"issue":"2","key":"712_CR41","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.immuni.2005.06.008","volume":"23","author":"K Karik\u00f3","year":"2005","unstructured":"Karik\u00f3 K, Buckstein M, Ni H, Weissman D (2005) Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA. Immunity 23(2):165\u2013175. https:\/\/doi.org\/10.1016\/j.immuni.2005.06.008","journal-title":"Immunity"},{"key":"712_CR42","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s40164-020-00180-4","volume":"9","author":"EU Haq","year":"2020","unstructured":"Haq EU, Yu J, Guo J (2020) Frontiers in the COVID-19 vaccines development. Exp Hematol Oncol 9:24. https:\/\/doi.org\/10.1186\/s40164-020-00180-4","journal-title":"Exp Hematol Oncol"},{"issue":"7841","key":"712_CR43","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/d41586-021-00019-w","volume":"589","author":"E Dolgin","year":"2021","unstructured":"Dolgin E (2021) How COVID unlocked the power of RNA vaccines. Nature 589(7841):189\u2013191. https:\/\/doi.org\/10.1038\/d41586-021-00019-w","journal-title":"Nature"},{"issue":"27","key":"712_CR44","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","volume":"383","author":"FP Polack","year":"2020","unstructured":"Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S, Perez JL, P\u00e9rez Marc G, Moreira ED, Zerbini C, Bailey R, Swanson KA, Roychoudhury S, Koury K, Li P, Kalina WV, Cooper D, Frenck RW Jr, Hammitt LL, T\u00fcreci \u00d6, Nell H, Schaefer A, \u00dcnal S, Tresnan DB, Mather S, Dormitzer PR, \u015eahin U, Jansen KU, Gruber WC, C4591001 Clinical Trial Group (2020) Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine. N Engl J Med 383(27):2603\u20132615. https:\/\/doi.org\/10.1056\/NEJMoa2034577","journal-title":"N Engl J Med"},{"issue":"5","key":"712_CR45","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/NEJMoa2035389","volume":"384","author":"LR Baden","year":"2021","unstructured":"Baden LR, El Sahly EL, Essink B, Kotloff K, Frey S, Novak R, Diemert D, Spector SA, Rouphael N, Creech CB, McGettigan J, Khetan S, Segall N, Solis J, Brosz A, Fierro C, Schwartz H, Neuzil K, Corey L, Gilbert P, Janes H, Follmann D, Marovich M, Mascola J, Polakowski L, Ledgerwood J, Graham BS, Bennett H, Pajon R, Knightly C, Leav B, Deng W, Zhou H, Han S, Ivarsson M, Miller J, Zaks T, COVE Study Group (2021) Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N Engl J Med 384(5):403\u2013416. https:\/\/doi.org\/10.1056\/NEJMoa2035389","journal-title":"N Engl J Med"},{"key":"712_CR46","unstructured":"BioNTech (2021) mRNA vaccines to address the COVID-19 pandemic. BioNTech. https:\/\/biontech.de\/covid-19-portal\/mrna-vaccines. Accessed 2 Nov 2021"},{"issue":"2","key":"712_CR47","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s15006-021-9577-4","volume":"163","author":"H Holzgreve","year":"2021","unstructured":"Holzgreve H (2021) COVID-19: Nobelpreisw\u00fcrdiger Erfolg in der Impfstoff-Forschung. MMW Fortschr Med 163(2):24\u201325. https:\/\/doi.org\/10.1007\/s15006-021-9577-4","journal-title":"MMW Fortschr Med"},{"issue":"6","key":"712_CR48","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1002\/biuz.19880180606","volume":"18","author":"F Wunderlich","year":"1988","unstructured":"Wunderlich F, Schmitt-Wrede HP (1988) Malaria-Vakzine: Erste Versuche am Menschen. Biol unserer Zeit 18(6):189\u2013195. https:\/\/doi.org\/10.1002\/biuz.19880180606","journal-title":"Biol unserer Zeit"},{"issue":"5","key":"712_CR49","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1001\/jama.1974.03230430063035","volume":"229","author":"TH Juke","year":"1974","unstructured":"Juke TH (1974) DDT. JAMA 229(5):571\u2013573","journal-title":"JAMA"},{"issue":"11","key":"712_CR50","doi-asserted-by":"publisher","first-page":"1940","DOI":"10.2105\/AJPH.2007.122523","volume":"98","author":"O\u00b4Shaughnessy PT,","year":"2008","unstructured":"O\u00b4Shaughnessy PT, (2008) Parachuting cats and crushed eggs the controversy over the use of DDT to control malaria. Am J Public Health 98(11):1940\u20131948. https:\/\/doi.org\/10.2105\/AJPH.2007.122523","journal-title":"Am J Public Health"},{"issue":"8","key":"712_CR51","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.2105\/AJPH.2009.163717","volume":"99","author":"HH Chen","year":"2009","unstructured":"Chen HH, Chen ALT (2009) Indoor residual spraying of DDT for malaria control. Am J Public Health 99(8):1350\u20131351. https:\/\/doi.org\/10.2105\/AJPH.2009.163717","journal-title":"Am J Public Health"},{"issue":"7423","key":"712_CR52","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1136\/bmj.327.7423.1078","volume":"327","author":"P Schlagenhauf","year":"2003","unstructured":"Schlagenhauf P, Tschopp A, Johnson R, Nothdurft HD, Beck B, Schwartz E, Herold M, Krebs B, Veit O, Allwinn R, Steffen R (2003) Tolerability of malaria chemoprophylaxis in non-immune travellers to sub-Sahara Africa: multicentre, randomised, double blind, four arm study. BMJ 327(7423):1078. https:\/\/doi.org\/10.1136\/bmj.327.7423.1078","journal-title":"BMJ"},{"issue":"6","key":"712_CR53","first-page":"57","volume":"47","author":"Arznei-Telegramm,","year":"2016","unstructured":"Arznei-Telegramm, (2016) Malariaphrophylaxe nach dem Mefloquin (Lariam)-R\u00fcckzug. Arznei-Telegramm 47(6):57\u201359","journal-title":"Arznei-Telegramm"},{"issue":"3","key":"712_CR54","first-page":"14","volume":"49","author":"D Baxby","year":"1999","unstructured":"Baxby D (1999) The end of smallpox. Hist Today 49(3):14\u201316","journal-title":"Hist Today"},{"issue":"8","key":"712_CR55","first-page":"317","volume":"43","author":"Y Borkens","year":"2020","unstructured":"Borkens Y (2020) Ist eine Malaria-Impfung m\u00f6glich? \u2013 Verschiedene Impfkandidaten und ihr Potenzial gegen Plasmodium-Parasiten. Med Monatsschr Pharm 43(8):317\u2013321","journal-title":"Med Monatsschr Pharm"},{"issue":"4","key":"712_CR56","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1080\/14760584.2017.1276833","volume":"16","author":"M Theisen","year":"2017","unstructured":"Theisen M, Jore MM, Sauerwein R (2017) Towards clinical development of a Pfs48\/45-based transmission blocking malaria vaccine. Expert Rev Vaccines 16(4):329\u2013336. https:\/\/doi.org\/10.1080\/14760584.2017.1276833","journal-title":"Expert Rev Vaccines"},{"key":"712_CR57","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/nri1746","volume":"6","author":"AVS Hill","year":"2006","unstructured":"Hill AVS (2006) Pre-erythrocytic malaria vaccines: towards greater efficacy. Nat Rev Immunol 6:21\u201332. https:\/\/doi.org\/10.1038\/nri1746","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"712_CR58","doi-asserted-by":"publisher","first-page":"400","DOI":"10.3390\/vaccines8030400","volume":"8","author":"C Maques-da-Silva","year":"2020","unstructured":"Maques-da-Silva C, Peissig K, Kurup SP (2020) Pre-erythrocytic vaccines against malaria. Vaccines 8(3):400. https:\/\/doi.org\/10.3390\/vaccines8030400","journal-title":"Vaccines"},{"issue":"3","key":"712_CR59","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1179\/136485910X12647085215534","volume":"104","author":"AL Goodman","year":"2010","unstructured":"Goodman AL, Draper SJ (2010) Blood-stage malaria vaccines\u2014recent progress and future challenges. Ann Trop Med Parasitol 104(3):189\u2013211. https:\/\/doi.org\/10.1179\/136485910X12647085215534","journal-title":"Ann Trop Med Parasitol"},{"issue":"7","key":"712_CR60","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/0264-410x(94)90261-5","volume":"12","author":"MC L\u00f3pez","year":"1994","unstructured":"L\u00f3pez MC, Silva Y, Thomas MC, Garcia A, Faus MJ, Alonso P, Martinez F, Del Real G, Alonso C (1994) Characterization of SPf(66)n: a chimeric molecule used as a malaria vaccine. Vaccine 12(7):585\u2013591. https:\/\/doi.org\/10.1016\/0264-410x(94)90261-5","journal-title":"Vaccine"},{"key":"712_CR61","unstructured":"Brown P (1999) Scientist whose dream of beating disease came true. The Guardian. https:\/\/www.theguardian.com\/uk\/1999\/jul\/24\/paulbrown. Accessed 24 Nov 2021"},{"key":"712_CR62","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005966","author":"PM Graves","year":"2006","unstructured":"Graves PM, Gelband H, Cochrane Infectious Disease Group (2006) Vaccines for preventing malaria (SPf66). Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD005966","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"712_CR63","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/0952-7915(95)80065-4","volume":"7","author":"E Riley","year":"1995","unstructured":"Riley E (1995) Malaria vaccine trials: SPf66 and all that. Curr Opin Immunol 7(5):612\u2013616. https:\/\/doi.org\/10.1016\/0952-7915(95)80065-4","journal-title":"Curr Opin Immunol"},{"issue":"12","key":"712_CR64","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1046\/j.1365-3024.1997.d01-171.x","volume":"19","author":"KA Bojang","year":"1997","unstructured":"Bojang KA, Obaro SK, Leach A, D\u2019Alessandro U, Bennett S, Metzger W, Ballou WR, Target GA, Greenwood BM (1997) Follow-up of Gambian children recruited to a pilot safety and immunogenicity study of the malaria vaccine SPf66. Parasite Immunol 19(12):579\u2013581. https:\/\/doi.org\/10.1046\/j.1365-3024.1997.d01-171.x","journal-title":"Parasite Immunol"},{"issue":"7182","key":"712_CR65","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1038\/4511042a","volume":"451","author":"B Maher","year":"2008","unstructured":"Maher B (2008) Malaria: the end of the beginning. Nature 451(7182):1042\u20131046. https:\/\/doi.org\/10.1038\/4511042a","journal-title":"Nature"},{"issue":"1","key":"712_CR66","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s00103-019-03070-1","volume":"63","author":"WG Metzger","year":"2019","unstructured":"Metzger WG, Sulyok Z, Theurer A, K\u00f6hler C (2019) Entwicklung von Impfstoffen gegen Malaria \u2013 aktueller Stand. Bundesgesundheitsbl 63(1):45\u201355. https:\/\/doi.org\/10.1007\/s00103-019-03070-1","journal-title":"Bundesgesundheitsbl"},{"issue":"10182","key":"712_CR67","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1016\/S0140-6736(19)30937-7","volume":"393","author":"P Adepoju","year":"2019","unstructured":"Adepoju P (2019) RTS, S malaria vaccine pilots in three African countries. Lancet 393(10182):1685. https:\/\/doi.org\/10.1016\/S0140-6736(19)30937-7","journal-title":"Lancet"},{"issue":"9","key":"712_CR68","doi-asserted-by":"publisher","first-page":"2098","DOI":"10.1080\/21645515.2017.1295906","volume":"13","author":"S Mahmoudi","year":"2017","unstructured":"Mahmoudi S, Keshavarz H (2017) Efficacy of phase 3 trial of RTS, S\/AS01 malaria vaccine: the need for an alternative development plan. Hum Vaccine Immunother 13(9):2098\u20132101. https:\/\/doi.org\/10.1080\/21645515.2017.1295906","journal-title":"Hum Vaccine Immunother"},{"issue":"7754","key":"712_CR69","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/d41586-019-01342-z","volume":"569","author":"A Maxmen","year":"2019","unstructured":"Maxmen A (2019) First proven malaria vaccine rolled out in Africa\u2014but doubts linger. Nature 569(7754):14\u201315. https:\/\/doi.org\/10.1038\/d41586-019-01342-z","journal-title":"Nature"},{"issue":"10005","key":"712_CR70","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1016\/S0140-6736(15)00694-7","volume":"386","author":"O M\u00fcller","year":"2015","unstructured":"M\u00fcller O, Tozan Y, Becher H (2015) RTS, S\/AS01 malaria vaccine and child mortality. Lancet 386(10005):1736. https:\/\/doi.org\/10.1016\/S0140-6736(15)00694-7","journal-title":"Lancet"},{"issue":"2","key":"712_CR71","doi-asserted-by":"publisher","first-page":"e00514","DOI":"10.1128\/mBio.00514-16","volume":"7","author":"SL Klein","year":"2016","unstructured":"Klein SL, Shann F, Moss WJ, Benn CS, Aaby P (2016) RTS, S malaria vaccine and increased mortality in girls. MBio 7(2):e00514-e516. https:\/\/doi.org\/10.1128\/mBio.00514-16","journal-title":"MBio"},{"issue":"10005","key":"712_CR72","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1016\/S0140-6736(15)00693-5","volume":"386","author":"P Aaby","year":"2015","unstructured":"Aaby P, Rodriguez A, Kofoed PE, Benn CS (2015) RTS, S\/AS01 malaria vaccine and child mortality. Lancet 386(10005):1735\u20131736. https:\/\/doi.org\/10.1016\/S0140-6736(15)00693-5","journal-title":"Lancet"},{"issue":"9988","key":"712_CR73","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0140-6736(15)60721-8","volume":"386","author":"RTS, S Clinical Trials Partnership","year":"2015","unstructured":"RTS, S Clinical Trials Partnership (2015) Efficacy and safety of RTS, S\/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial. Lancet 386(9988):31\u201345. https:\/\/doi.org\/10.1016\/S0140-6736(15)60721-8","journal-title":"Lancet"},{"issue":"8","key":"712_CR74","first-page":"429","volume":"36","author":"C Becker","year":"2015","unstructured":"Becker C (2015) Wirksamkeit und Sicherheit des RTS, S\/AS01-Malaria-Impfstoffs mit oder ohne Auffrischungs-Impfung bei S\u00e4uglingen und Kleinkindern. Krankenhauspharmazie 36(8):429\u2013430","journal-title":"Krankenhauspharmazie"},{"issue":"10287","key":"712_CR75","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1016\/S0140-6736(21)00943-0","volume":"397","author":"MS Datoo","year":"2021","unstructured":"Datoo MS, Natama MH, Som\u00e9 A, Traor\u00e9 O, Rouamba T, Bellamy D, Yameogo P, Valia D, Tegneri M, Ouedraogo F, Soma R, Sawadogo S, Sorgho F, Derra K, Rouamba E, Orindi B, Lopez FR, Flaxman A, Cappuccini F, Kailath R, Elias S, Mukhopadhyay E, Noe A, Cairns M, Lawrie A, Roberts R, Val\u00e9a I, Sorgho H, Williams N, Gleen G, Fries L, Reimer J, Ewer KJ, Shaligram U, Hill AVS, Tinto H (2021) Efficacy of a low-dose candidate malaria vaccine, R21 in adjuvant Matrix-M, with seasonal administration to children in Burkina Faso: a randomised controlled trial. Lancet 397(10287):1809\u20131818. https:\/\/doi.org\/10.1016\/S0140-6736(21)00943-0","journal-title":"Lancet"},{"issue":"10287","key":"712_CR76","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1016\/S0140-6736(21)01065-5","volume":"397","author":"V Moorthy","year":"2021","unstructured":"Moorthy V, Binka F (2021) R21\/Matrix-M: a second malaria vaccine? Lancet 397(10287):1782\u20131783. https:\/\/doi.org\/10.1016\/S0140-6736(21)01065-5","journal-title":"Lancet"},{"key":"712_CR77","unstructured":"Heise G (2021) Gibt es bald eine wirksame Malaria-Impfung? Deutsche Welle. https:\/\/www.dw.com\/de\/gibt-es-bald-eine-wirksame-malaria-impfung\/a-58879233. Accessed 12 Apr 2022."},{"issue":"1","key":"712_CR78","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.89154","volume":"2","author":"JE Epstein","year":"2017","unstructured":"Epstein JE, Paolino KM, Richie TL, Sedegah M, Singer A, Ruben AJ, Chakravarty S, Stafford A, Ruck RC, Eappen AG, Li T, Billingsley PF, Manoj A, Silva JC, Moser K, Nielsen R, Tosh D, Cicatelli S, Ganeshan H, Case J, Padilla D, Davidson S, Garver L, Saverino E, Murshedkar T, Gunasekera A, Twomey PS, Reyes S, Moon JE, James ER, Kc N, Li M, Abot E, Belmonte A, Hauns K, Belmonte M, Huang J, Vasquez C, Remich S, Carrington M, Abebe Y, Tillman A, Hickey B, Regules J, Villasante E, Sim BKL, Hoffman SL (2017) Protection against Plasmodium falciparum malaria by PfSPZ Vaccine. JCI Insight 2(1):e89154. https:\/\/doi.org\/10.1172\/jci.insight.89154","journal-title":"JCI Insight"},{"issue":"7642","key":"712_CR79","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/nature21060","volume":"542","author":"B Mordm\u00fcller","year":"2017","unstructured":"Mordm\u00fcller B, Surat G, Lagler H, Chakravarty S, Ishizuka AS, Lalremruata A, Gmeiner M, Campo JJ, Esen M, Ruben AJ, Held J, Calle CL, Mengue JB, Gebru T, Ib\u00e1\u00f1ez J, Sulyok M, James ER, Billingsley PF, Natasha KC, Manoj A, Murshedkar T, Gunasekera A, Eappen AG, Li T, Stafford RE, Li M, Felgner PL, Seder RA, Richie TL, Sim BKL, Hoffman SL, Kremsner PG (2017) Sterile protection against human malaria by chemoattenuated PfSPZ vaccine. Nature 542(7642):445\u2013449. https:\/\/doi.org\/10.1038\/nature21060","journal-title":"Nature"},{"issue":"7022","key":"712_CR80","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1038\/nature03188","volume":"433","author":"AK Mueller","year":"2005","unstructured":"Mueller AK, Labaied M, Kappe SHI, Matuschewski K (2005) Genetically modified Plasmodium parasites as a protective experimental malaria vaccine. Nature 433(7022):164\u2013167. https:\/\/doi.org\/10.1038\/nature03188","journal-title":"Nature"},{"issue":"1","key":"712_CR81","doi-asserted-by":"publisher","first-page":"107","DOI":"10.2353\/ajpath.2007.060792","volume":"171","author":"AK Mueller","year":"2007","unstructured":"Mueller AK, Deckert M, Heiss K, Goetz K, Matuschewski K, Schl\u00fcter D (2007) Genetically attenuated Plasmodium berghei liver stages persist and elicit sterile protection primarily via CD8 T cells. Am J Pathol 171(1):107\u2013115. https:\/\/doi.org\/10.2353\/ajpath.2007.060792","journal-title":"Am J Pathol"},{"issue":"4","key":"712_CR82","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1086\/519742","volume":"196","author":"AS Tarun","year":"2007","unstructured":"Tarun AS, Dumpit RF, Camargo N, Labaied M, Liu P, Takagi A, Wang R, Kappe SHI (2007) Protracted sterile protection with Plasmodium yoelii pre-erythrocytic genetically attenuated parasite malaria vaccines is independent of significant liver-stage persistence and is mediated by CD8+ T cells. J Infect Dis 196(4):608\u2013616. https:\/\/doi.org\/10.1086\/519742","journal-title":"J Infect Dis"},{"issue":"1\u20133","key":"712_CR83","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/0303-7207(91)90275-2","volume":"76","author":"HP Schmitt-Wrede","year":"1991","unstructured":"Schmitt-Wrede HP, Fiebig S, Wunderlich F, Benten WPM, Bettenh\u00e4user U, Boden K, Mossmann H (1991) Testosterone-induced susceptibility to Plasmodium chabaudi malaria: variant protein expression in functionally changed splenic non-T cells. Mol Cell Endocrinol 76(1\u20133):207\u2013214. https:\/\/doi.org\/10.1016\/0303-7207(91)90275-2","journal-title":"Mol Cell Endocrinol"},{"issue":"1","key":"712_CR84","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1128\/IAI.73.1.436-443.2005","volume":"73","author":"J Kr\u00fccken","year":"2005","unstructured":"Kr\u00fccken J, Dkhil MA, Braun JV, Schroetel RMU, El-Khadragy M, Carmeliet P, Mossmann H, Wunderlich F (2005) Testosterone suppresses protective responses of the liver to blood-stage malaria. Infect Immun 73(1):436\u2013443. https:\/\/doi.org\/10.1128\/IAI.73.1.436-443.2005","journal-title":"Infect Immun"},{"issue":"11","key":"712_CR85","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1016\/0264-410x(93)90068-9","volume":"11","author":"F Wunderlich","year":"1993","unstructured":"Wunderlich F, Maurin W, Benten WPM, Schmitt-Wrede HP (1993) Testosterone impairs efficacy of protective vaccination against P. chabaudi malaria. Vaccine 11(11):1097\u20131099. https:\/\/doi.org\/10.1016\/0264-410x(93)90068-9","journal-title":"Vaccine"},{"key":"712_CR86","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.ijpddr.2012.05.002","volume":"2","author":"FS Buckner","year":"2012","unstructured":"Buckner FS, Waters NC, Avery VM (2012) Recent highlights in anti-protozoan drug development and resistance research. Int J Parasitol Drugs Drug Resist 2:230\u2013235. https:\/\/doi.org\/10.1016\/j.ijpddr.2012.05.002","journal-title":"Int J Parasitol Drugs Drug Resist"},{"issue":"2","key":"712_CR87","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.ijpddr.2014.02.002","volume":"4","author":"KT Andrews","year":"2014","unstructured":"Andrews KT, Fisher G, Skinner-Adams TS (2014) Drug repurposing and human parasitic protozoan diseases. Int J Parasitol Drugs Drug Resist 4(2):95\u2013111. https:\/\/doi.org\/10.1016\/j.ijpddr.2014.02.002","journal-title":"Int J Parasitol Drugs Drug Resist"},{"issue":"11","key":"712_CR88","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.4161\/rna.22269","volume":"9","author":"T Schlake","year":"2012","unstructured":"Schlake T, Thess A, Fotin-Mleczek M, Kallen KJ (2012) Developing mRNA-vaccine technologies. RNA Biol 9(11):1319\u20131330. https:\/\/doi.org\/10.4161\/rna.22269","journal-title":"RNA Biol"},{"key":"712_CR89","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-1-4939-6481-9_1","volume":"1499","author":"T Kramps","year":"2017","unstructured":"Kramps T, Elbers K (2017) Introduction to RNA vaccines. Methods Mol Biol 1499:1\u201311. https:\/\/doi.org\/10.1007\/978-1-4939-6481-9_1","journal-title":"Methods Mol Biol"},{"issue":"1","key":"712_CR90","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.mib.2005.11.001","volume":"9","author":"S Hammerschmidt","year":"2006","unstructured":"Hammerschmidt S (2006) Adherence molecules of pathogenic pneumococci. Curr Opin Microbiol 9(1):12\u201320. https:\/\/doi.org\/10.1016\/j.mib.2005.11.001","journal-title":"Curr Opin Microbiol"},{"issue":"4","key":"712_CR91","first-page":"579","volume":"31","author":"RD Liu","year":"2014","unstructured":"Liu RD, Cui J, Wang L, Long SR, Zhang X, Liu MY, Wang ZQ (2014) Identification of surface proteins of Trichinella spiralis muscle larvae using immunoproteomics. Trop Biomed 31(4):579\u2013591","journal-title":"Trop Biomed"},{"issue":"7427","key":"712_CR92","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/nature11759","volume":"492","author":"SB Gould","year":"2012","unstructured":"Gould SB (2012) Evolutionary genomics: algaes complex origins. Nature 492(7427):46\u201348. https:\/\/doi.org\/10.1038\/nature11759","journal-title":"Nature"},{"issue":"12","key":"712_CR93","doi-asserted-by":"publisher","first-page":"R515","DOI":"10.1016\/j.cub.2015.04.033","volume":"25","author":"SB Gould","year":"2015","unstructured":"Gould SB, Maier UG, Martin WF (2015) Protein import and the origin of red complex plastids. Curr Biol 25(12):R515\u2013R521. https:\/\/doi.org\/10.1016\/j.cub.2015.04.033","journal-title":"Curr Biol"},{"issue":"4","key":"712_CR94","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1007\/s00709-010-0250-5","volume":"248","author":"GI McFadden","year":"2011","unstructured":"McFadden GI (2011) The apicoplast. Protoplasma 248(4):641\u2013650. https:\/\/doi.org\/10.1007\/s00709-010-0250-5","journal-title":"Protoplasma"},{"issue":"9\u201310","key":"712_CR95","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.micinf.2017.12.005","volume":"20","author":"LM Low","year":"2018","unstructured":"Low LM, Stanisic DI, Good MF (2018) Exploiting the apicoplast: apicoplast-targeting drugs and malaria vaccine development. Microbes Infect 20(9\u201310):477\u2013483. https:\/\/doi.org\/10.1016\/j.micinf.2017.12.005","journal-title":"Microbes Infect"},{"issue":"8","key":"712_CR96","doi-asserted-by":"publisher","first-page":"R381","DOI":"10.1016\/j.cub.2018.01.086","volume":"28","author":"SB Gould","year":"2018","unstructured":"Gould SB (2018) Membranes and evolution. Curr Biol 28(8):R381\u2013R385. https:\/\/doi.org\/10.1016\/j.cub.2018.01.086","journal-title":"Curr Biol"},{"issue":"39","key":"712_CR97","doi-asserted-by":"publisher","first-page":"26951","DOI":"10.1074\/jbc.M109.013706","volume":"284","author":"ML Plassmeyer","year":"2009","unstructured":"Plassmeyer ML, Reiter K, Shimp RL Jr., Kotova S, Smith PD, Hurt DE, House B, Zou X, Zhang Y, Hickman M, Uchime O, Herrera R, Nguyen V, Glen J, Lebowitz J, Jin AJ, Miller LH, MacDonald NJ, Wu Y, Narum DL (2009) Structure of the Plasmodium falciparum circumsporozoite protein, a leading malaria vaccine candidate. J Biol Chem 284(39):26951\u201326963. https:\/\/doi.org\/10.1074\/jbc.M109.013706","journal-title":"J Biol Chem"},{"issue":"9","key":"712_CR98","doi-asserted-by":"publisher","first-page":"7092","DOI":"10.1074\/jbc.M106862200","volume":"277","author":"D Rathore","year":"2002","unstructured":"Rathore D, Sacci JB, de la Vega P, McCutchan TF (2002) Binding and invasion of liver cells by Plasmodium falciparum sporozoites. Essential involvement of the amino terminus of circumsporozoite protein. J Biol Chem 277(9):7092\u20137098. https:\/\/doi.org\/10.1074\/jbc.M106862200","journal-title":"J Biol Chem"},{"issue":"10","key":"712_CR99","doi-asserted-by":"publisher","first-page":"eaau8529","DOI":"10.1126\/sciadv.aau8529","volume":"4","author":"D Oyen","year":"2018","unstructured":"Oyen D, Torres JL, Cottrell CA, Richter King C, Wilson IA, Ward AB (2018) Cryo-EM structure of P. falciparum circumsporozoite protein with a vaccine-elicited antibody is stabilized by somatically mutated inter-Fab contacts. Sci Adv 4(10):eaau8529. https:\/\/doi.org\/10.1126\/sciadv.aau8529","journal-title":"Sci Adv"},{"issue":"1","key":"712_CR100","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.exppara.2009.02.010","volume":"6","author":"KL Mallory","year":"2021","unstructured":"Mallory KL, Taylor JA, Zou X, Waghela IN, Schneider CG, Sibilo MQ, Punde NM, Perazzo LC, Savransky T, Sedegah M, Dutta S, Janse CJ, Pardi N, Lin PJC, Tam YK, Weissman D, Angov E (2021) Messenger RNA expressing PfCSP induces functional, protective immune response against malaria in mice. NPJ Vaccines 6(1):84. https:\/\/doi.org\/10.1016\/j.exppara.2009.02.010","journal-title":"NPJ Vaccines"},{"issue":"3","key":"712_CR101","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1093\/femsre\/fuw001","volume":"40","author":"JG Beeson","year":"2016","unstructured":"Beeson JG, Drew DR, Boyle MJ, Feng G, Fowkes FJI, Richards JS (2016) Merozoite surface proteins in red blood cell invasion, immunity and vaccines against malaria. FEMS Microbiol Rev 40(3):343\u2013372. https:\/\/doi.org\/10.1093\/femsre\/fuw001","journal-title":"FEMS Microbiol Rev"},{"issue":"1","key":"712_CR102","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0166-6851(93)90002-f","volume":"59","author":"JH Miller","year":"1993","unstructured":"Miller JH, Roberts T, Shahabuddin M, McCutchan TF (1993) Analysis of sequence diversity in the Plasmodium falciparum merozoite surface protein-1 (MSP-1). Mol Biochem Parasitol 59(1):1\u201314. https:\/\/doi.org\/10.1016\/0166-6851(93)90002-f","journal-title":"Mol Biochem Parasitol"},{"issue":"7214","key":"712_CR103","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/nature07306","volume":"455","author":"A Pain","year":"2008","unstructured":"Pain A, B\u00f6hme U, Berry AE, Mungall K, Finn RD, Jackson AP, Mourier T, Mistry J, Pasini EM, Aslett MA, Balasubrammaniam S, Borgwardt K, Brooks K, Carret C, Carver TJ, Cherevach I, Chillingworth T, Clark TG, Galinski MR, Hall N, Harper D, Harris D, Hauser H, Ivens A, Janssen CS, Keane T, Larke N, Lapp S, Marti M, Moule S, Meyer IM, Ormond D, Peters N, Sanders M, Sanders S, Sargeant TJ, Simmonds M, Smith F, Squares R, Thurston S, Tivey AR, Walker D, White B, Zuiderwijk E, Churcher C, Quail MA, Cowman AF, Turner CMR, Rajandream MA, Kocken CHM, Thomas AW, Newbold CI, Barrell BG, Berriman M (2008) The genome of the simian and human malaria parasite Plasmodium knowlesi. Nature 455(7214):799\u2013803. https:\/\/doi.org\/10.1038\/nature07306","journal-title":"Nature"},{"key":"712_CR104","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/1475-2875-11-46","volume":"11","author":"A Baumann","year":"2012","unstructured":"Baumann A, Magris MM, Urbaez ML, Vivas-Martinez S, Dur\u00e1n R, Nieves T, Esen M, Mordm\u00fcller BG, Theisen M, Avilan L, Metzger WG (2012) Naturally acquired immune response to malaria vaccine candidate antigens MSP3 and GLURP in Guahibo and Piaroa indigenous communities of the Venezuelan Amazon. Malar J 11:46. https:\/\/doi.org\/10.1186\/1475-2875-11-46","journal-title":"Malar J"},{"issue":"1","key":"712_CR105","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1186\/s12936-021-03815-x","volume":"20","author":"L Ndwiga","year":"2021","unstructured":"Ndwiga L, Osoti V, Ochwedo KO, Wamae K, Bejon P, Rayner JC, Githinji G, Ochola-Oyier LI (2021) The Plasmodium falciparum Rh5 invasion protein complex reveals an excess of rare variant mutations. Malar J 20(1):278. https:\/\/doi.org\/10.1186\/s12936-021-03815-x","journal-title":"Malar J"},{"issue":"1","key":"712_CR106","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.chom.2008.06.001","volume":"4","author":"K Hayton","year":"2008","unstructured":"Hayton K, Gaur D, Liu A, Takahashi J, Henschen B, Singh S, Lambert L, Furuya T, Bouttenot R, Doll M, Nawaz F, Mu J, Jiang L, Miller LH, Wellems TE (2008) Erythrocyte binding protein PfRH5 polymorphisms determine species-specific pathways of Plasmodium falciparum invasion. Cell Host Microbe 4(1):40\u201351. https:\/\/doi.org\/10.1016\/j.chom.2008.06.001","journal-title":"Cell Host Microbe"},{"issue":"7378","key":"712_CR107","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1038\/nature10606","volume":"480","author":"C Crosnier","year":"2011","unstructured":"Crosnier C, Bustamante LY, Bartholdson SJ, Bei AK, Theron M, Uchikawa M, Mboup S, Ndir O, Kwiatkowski DP, Duraisingh MT, Rayner JC, Wright GJ (2011) Basigin is a receptor essential for erythrocyte invasion by Plasmodium falciparum. Nature 480(7378):534\u2013537. https:\/\/doi.org\/10.1038\/nature10606","journal-title":"Nature"},{"issue":"10","key":"712_CR108","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1517\/14728222.2012.711818","volume":"16","author":"T Muramatsu","year":"2012","unstructured":"Muramatsu T (2012) Basigin: a multifunctional membrane protein with an emerging role in infections by malaria parasites. Expert Opin Ther Targets 16(10):999\u20131011. https:\/\/doi.org\/10.1517\/14728222.2012.711818","journal-title":"Expert Opin Ther Targets"},{"issue":"1","key":"712_CR109","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.cell.2019.05.025","volume":"178","author":"DGW Alanine","year":"2019","unstructured":"Alanine DGW, Quinkert D, Kumarasingha R, Mehmood S, Donnellan FR, Minkah NK, Dadonaite B, Diouf A, Galaway F, Silk SE, Jamwal A, Marshall JM, Miura K, Foquet L, Elias SE, Labb\u00e9 GM, Douglas AD, Jin J, Payne RO, Illingworth JJ, Pattinson DJ, Pulido D, Williams BG, de Jongh WA, Wright GJ, Kappe SHI, Robinson CV, Long CA, Crabb BS, Gilson PR, Higgins MK, Draper SJ (2019) Human antibodies that slow erythrocyte invasion potentiate malaria-neutralizing antibodies. Cell 178(1):216-228.e21. https:\/\/doi.org\/10.1016\/j.cell.2019.05.025","journal-title":"Cell"},{"issue":"1","key":"712_CR110","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.chom.2016.06.004","volume":"20","author":"JC Volz","year":"2016","unstructured":"Volz JC, Yap A, Sisquella X, Thompson JK, Lim NTY, Whitehead LW, Chen L, Lampe M, Tham WH, Wilson D, Nebl T, Marapana D, Triglia T, Wong W, Rogers KL, Cowman AF (2016) Essential role of the PfRh5\/PfRipr\/CyRPA complex during Plasmodium falciparum invasion of erythrocytes. Cell Host Microbe 20(1):60\u201371. https:\/\/doi.org\/10.1016\/j.chom.2016.06.004","journal-title":"Cell Host Microbe"},{"issue":"6","key":"712_CR111","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1086\/339342","volume":"185","author":"B Genton","year":"2002","unstructured":"Genton B, Betuela I, Felger I, Al-Yaman F, Anders RF, Saul A, Rare L, Baisor M, Lorry K, Brown GV, Pye D, Irving DO, Smith TA, Beck HP, Alpers MP (2002) A recombinant blood-stage malaria vaccine reduces Plasmodium falciparum density and exerts selective pressure on parasite populations in a phase 1\u20132b trial in Papua New Guinea. J Infect Dis 185(6):820\u2013827. https:\/\/doi.org\/10.1086\/339342","journal-title":"J Infect Dis"},{"issue":"5","key":"712_CR112","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1084\/jem.174.5.1203","volume":"174","author":"PJ Barr","year":"1991","unstructured":"Barr PJ, Green KM, Gibson HL, Bathurst IC, Quakyi IA, Kaslow DC (1991) Recombinant Pfs25 protein of Plasmodium falciparum elicits malaria transmission-blocking immunity in experimental animals. J Exp Med 174(5):1203\u20131208. https:\/\/doi.org\/10.1084\/jem.174.5.1203","journal-title":"J Exp Med"},{"key":"712_CR113","doi-asserted-by":"publisher","first-page":"694759","DOI":"10.3389\/fimmu.2021.694759","volume":"12","author":"H de Graaf","year":"2021","unstructured":"de Graaf H, Payne RO, Taylor I, Miura K, Long CA, Elias SC, Zaric M, Minassin AM, Silk SE, Li L, Poulton ID, Baker M, Draper SJ, Gbesemete D, Brendish NJ, Martins F, Marini A, Mekhaiel D, Edwards NJ, Roberts R, Vekemans J, Moyle S, Faust SN, Berrie E, Lawrie AM, Hill F, Hill AVS, Biswas S (2021) Safety and immunogenicity of ChAd63\/MVA Pfs25-IMX313 in a phase I first-in-human trial. Front Immunol 12:694759. https:\/\/doi.org\/10.3389\/fimmu.2021.694759","journal-title":"Front Immunol"},{"key":"712_CR114","doi-asserted-by":"publisher","first-page":"732667","DOI":"10.3389\/fimmu.2021.732667","volume":"12","author":"M Zaric","year":"2021","unstructured":"Zaric M, Marini A, Nielsen CM, Gupta G, Mekhaiel D, Pham TP, Elias SC, Taylor IJ, de Graaf H, Payne RO, Li Y, Silk SE, Williams C, Hill AVS, Long CA, Miura K, Biswas S (2021) Poor CD4+ T Cell immunogenicity limits humoral immunity to P. falciparum transmission-blocking candidate Pfs25 in humans. Front Immunol 12:732667. https:\/\/doi.org\/10.3389\/fimmu.2021.732667","journal-title":"Front Immunol"},{"issue":"1","key":"712_CR115","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.chom.2018.06.008","volume":"24","author":"SJ Draper","year":"2018","unstructured":"Draper SJ, Sack BK, Richter King C, Nielsen CM, Rayner JC, Higgins MK, Long CA, Seder RA (2018) Malaria vaccines: recent advances and new horizons. Cell Host Microbe 24(1):43\u201356. https:\/\/doi.org\/10.1016\/j.chom.2018.06.008","journal-title":"Cell Host Microbe"},{"issue":"20","key":"712_CR116","doi-asserted-by":"publisher","first-page":"7817","DOI":"10.1073\/pnas.1205737109","volume":"109","author":"MB Doud","year":"2012","unstructured":"Doud MB, Koksal AC, Mi LZ, Song G, Lu C, Springer TA (2012) Unexpected fold in the circumsporozoite protein target of malaria vaccines. Proc Natl Acad Sci U S A 109(20):7817\u20137822. https:\/\/doi.org\/10.1073\/pnas.1205737109","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Acta Parasitologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11686-023-00712-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11686-023-00712-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11686-023-00712-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,22]],"date-time":"2023-11-22T09:23:58Z","timestamp":1700645038000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11686-023-00712-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,12]]},"references-count":116,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["712"],"URL":"https:\/\/doi.org\/10.1007\/s11686-023-00712-y","relation":{},"ISSN":["1230-2821","1896-1851"],"issn-type":[{"value":"1230-2821","type":"print"},{"value":"1896-1851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,12]]},"assertion":[{"value":"10 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The author declares no competing interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"No studies on humans or animals were performed by the author for this article. For the studies cited, the ethical guidelines stated therein apply in each case.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights"}}]}}